|
|
|
|
| | |
| | |
|
|
|
|
| | |
| |
 |
|
|
 |
|
| | |
共同研究者 |
: |
田口惇美(新潟大学) |
研究テーマ |
: |
ファブリー病モデルマウスの作製と応用 |
|
|
|
| |
|
|
|
|
| |  | | | 1) | Taguchi
T, Maruyama H, Nameta M, Yamamoto T, Matsuda J, Kulkarni A, Yoshioka H,
and Ishii S: A symptomatic Fabry disease mouse model generated by
inducing globotrialceramide synthesis. Biochem J 456, 373-383, 2013. |  | | | | 2) | Shiozuka
C, Taguchi A, Matsuda J, Noguchi Y, Kunieda T, Uchio-Yamada K, Yoshioka
H, Hamanaka R, Yano S, Yokoyama S, Mannen K, Kulkarni AB, Furukawa K,
Ishii S: Increased globotriaosylceramide levels in a transgenic mouse
expressing human. J Biochem 149, 161-17-, 2011. |  | | | | 3) | Ishii
S, Chang H-H, Yoshioka H, Shimada T, Mannen K, Higuchi Y, Taguchi A,
Fan J-Q : Preclinical efficacy and safety of 1-deoxygalactonojirimycin
in mice for Fabry disease. J. Pharmacol. Exp. Ther. 328, 723-731, 2009. |  | | | |
|
|
|
| | |
|
| | |
|
| | |
| | | |
| | | |
 | | |
|
|
|
|
| | |
|